Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesDividends payablesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bruker (BRKR) Current Assets (2016 - 2025)

Bruker (BRKR) has disclosed Current Assets for 16 consecutive years, with $2.2 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Current Assets rose 7.76% year-over-year to $2.2 billion, compared with a TTM value of $2.2 billion through Dec 2025, up 7.76%, and an annual FY2025 reading of $2.2 billion, up 7.76% over the prior year.
  • Current Assets was $2.2 billion for Q4 2025 at Bruker, down from $2.4 billion in the prior quarter.
  • Across five years, Current Assets topped out at $2.5 billion in Q4 2021 and bottomed at $1.9 billion in Q1 2021.
  • Average Current Assets over 5 years is $2.1 billion, with a median of $2.1 billion recorded in 2023.
  • The sharpest move saw Current Assets increased 28.41% in 2021, then dropped 14.51% in 2022.
  • Year by year, Current Assets stood at $2.5 billion in 2021, then dropped by 14.51% to $2.1 billion in 2022, then grew by 2.41% to $2.2 billion in 2023, then decreased by 5.13% to $2.1 billion in 2024, then increased by 7.76% to $2.2 billion in 2025.
  • Business Quant data shows Current Assets for BRKR at $2.2 billion in Q4 2025, $2.4 billion in Q3 2025, and $2.2 billion in Q2 2025.